Theodrenaline: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
<div style="float: right;"> | |||
[[File:Theodrenaline.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | |||
| | |||
| | |||
| | |||
| | |||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
'''Theodrenaline''' ([[International Nonproprietary Name|INN]]), also known as '''noradrenalinoethyltheophylline''', is a chemical linkage of [[norepinephrine]] (noradrenaline) and [[theophylline]] used as a [[cardiac stimulant]]. | |||
It is sometimes combined with [[cafedrine]].<ref name="pmid16633089">{{cite journal |author=Usichenko TI |title=Akrinor-induced relaxation of pig coronary artery in vitro is transformed into alpha1-adrenoreceptor-mediated contraction by pretreatment with propranolol |journal=J. Cardiovasc. Pharmacol. |volume=47 |issue=3 |pages=450–5 |date=March 2006 |pmid=16633089 |doi=10.1097/01.fjc.0000211710.87863.89 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005344-200603000-00017 |author-separator=, |author2=Foellner S |author3=Gruendling M |display-authors=3 |last4=Feyerherd |first4=F |last5=Lehmann |first5=C |last6=Wendt |first6=M |last7=Pavlovic |first7=D}}</ref> | |||
==See also== | |||
* [[Cafedrine]] | |||
* [[Fenethylline]] | |||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
{{Cardiac stimulants excluding cardiac glycosides}} | {{Cardiac stimulants excluding cardiac glycosides}} | ||
{{Adenosinergics}} | |||
{{Adrenergics}} | |||
[[Category:Adenosine receptor antagonists]] | |||
[[Category:Catecholamines]] | [[Category:Catecholamines]] | ||
[[Category:Cardiac stimulants]] | |||
[[Category:Xanthines]] | [[Category:Xanthines]] | ||
[[Category:Drug]] | [[Category:Drug]] |
Revision as of 18:45, 7 April 2015
WikiDoc Resources for Theodrenaline |
Articles |
---|
Most recent articles on Theodrenaline Most cited articles on Theodrenaline |
Media |
Powerpoint slides on Theodrenaline |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Theodrenaline at Clinical Trials.gov Trial results on Theodrenaline Clinical Trials on Theodrenaline at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Theodrenaline NICE Guidance on Theodrenaline
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Theodrenaline Discussion groups on Theodrenaline Patient Handouts on Theodrenaline Directions to Hospitals Treating Theodrenaline Risk calculators and risk factors for Theodrenaline
|
Healthcare Provider Resources |
Causes & Risk Factors for Theodrenaline |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Theodrenaline (INN), also known as noradrenalinoethyltheophylline, is a chemical linkage of norepinephrine (noradrenaline) and theophylline used as a cardiac stimulant.
It is sometimes combined with cafedrine.[1]
See also
References
- ↑ Usichenko TI; Foellner S; Gruendling M; et al. (March 2006). "Akrinor-induced relaxation of pig coronary artery in vitro is transformed into alpha1-adrenoreceptor-mediated contraction by pretreatment with propranolol". J. Cardiovasc. Pharmacol. 47 (3): 450–5. doi:10.1097/01.fjc.0000211710.87863.89. PMID 16633089. Unknown parameter
|author-separator=
ignored (help)